Brizy
Tablet
Generic Name
Levosalbutamol
Manufacturer
Eskayef Pharmaceuticals Ltd.
Unit Price
Unit Price: ৳ 2.00 (5 x 10: ৳ 100.00) Strip Price: ৳ 20.00
🔹 Indications
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Pharmacology
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Dosage & Administration
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Interaction
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Contraindications
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Side Effects
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Pregnancy & Lactation
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Precautions & Warnings
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Storage Conditions
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
💡 Frequently Asked Questions
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
User Reviews
⭐
No reviews yet!
Be the first to share your experience.